Plasma D-dimer concentration in patients with systemic sclerosis
Tóm tắt
Systemic sclerosis (SSc) is an autoimmune disorder of the connective tissue characterized by widespread vascular lesions and fibrosis. Little is known so far on the activation of the hemostatic and fibrinolytic systems in SSc, and most preliminary evidences are discordant. To verify whether SSc patients might display a prothrombotic condition, plasma D-dimer was assessed in 28 consecutive SSc patients and in 33 control subjects, matched for age, sex and environmental habit. When compared to healthy controls, geometric mean and 95% confidence interval (IC95%) of plasma D-dimer were significantly increased in SSc patients (362 ng/mL, IC 95%: 361–363 ng/mL vs 229 ng/mL, IC95%: 228–231 ng/mL, p = 0.005). After stratifying SSc patients according to disease subset, no significant differences were observed between those with limited cutaneous pattern and controls, whereas patients with diffuse cutaneous pattern displayed substantially increased values. No correlation was found between plasma D-dimer concentration and age, sex, autoantibody pattern, serum creatinine, erythrosedimentation rate, nailfold videocapillaroscopic pattern and pulmonary involvement. We demonstrated that SSc patients with diffuse subset are characterized by increased plasma D-dimer values, reflecting a potential activation of both the hemostatic and fibrinolytic cascades, which might finally predispose these patients to thrombotic complications.
Tài liệu tham khảo
Kahaleh MB: Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004, 223(Suppl 33):S19-23.
Maeda M, Kachi H, Mori S: Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS). J Dermatol Sci 1996, 11: 223-7. 10.1016/0923-1811(95)00445-9
Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V: The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol 1997, 36: 1045-50. 10.1093/rheumatology/36.10.1045
Cerinic MM, Valentini G, Sorano GG, D'Angelo S, Cuomo G, Fenu L, Generini S, Cinotti S, Morfini M, Pignone A, Guiducci S, Del Rosso A, Kalfin R, Das D, Marongiu F: Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 2003, 32: 285-95. 10.1053/sarh.2002.50011
Prisco D, Antonucci E, Marcucci R, et al.: D-dimer in the year 2000 current data and new perspectives. Ann Ital Med Int 2000, 15: 267-72.
American Rheumatism Association Subcommittee for Scleroderma: Criteria of the Therapeutic Criteria Committee, preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23: 581-90.
Valentini G, Della Rossa A, Bombardieri S, et al.: European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001, 60: 592-8. 10.1136/ard.60.6.592
Medsger TA Jr, Bombardieri S, Czirjak L, et al.: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003, 21(3 Suppl 29):S42-6.
Arkel YS, Paidas MJ, Ku DH: The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders. Blood Coagul Fibrinolysis 2002, 13: 199-205. 10.1097/00001721-200204000-00005
Stegnar M, Vene N, Bozic M: Do haemostasis activation markers that predict cardiovascular disease exist? Pathophysiol Haemost Thromb 2003, 33: 302-8. 10.1159/000083818
Lopez Y, Paloma MJ, Rifon J, et al.: Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 1999, 93: 71-8. 10.1016/S0049-3848(98)00165-0
Lippi G, Mengoni A, Manzato F: Plasma D-dimer in the diagnosis of deep vein thrombosis. JAMA 1998, 280: 1828-9. 10.1001/jama.280.21.1828-b
Halevy D, Radhakrishnan J, Markowitz G, et al.: Thrombotic microangiopathies. Crit Care Clin 2002, 18: 309-20. 10.1016/S0749-0704(01)00004-5